Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury

Medicine and Dentistry

• Patient 100%
• Patient with Cerebral Palsy 41%
• Baclofen 41%
• Spastic Diplegia 37%
• Acquired Brain Injury 29%
• Spasticity 25%
• Adverse Event 20%
• Combination Therapy 16%
• Bolus Injection 16%
• Satisfaction 8%
• Therapeutic Procedure 8%
• Gait 4%
• Peroneus Nerve Paralysis 4%
• Brain Injury 4%
• Botulinum Toxin 4%
• Traumatic Brain Injury 4%
• Standing 4%
• Muscle Tone 4%

Nursing and Health Professions

• Baclofen 41%
• Inpatient 41%
• Cerebral Palsy 37%
• Acquired Brain Injury 29%
• Spasticity 25%
• Adverse Event 20%
• Combination Therapy 16%
• Bolus Injection 16%
• Intrathecal Baclofen Pump 12%
• Caregiver 8%
• Pump 8%
• Traumatic Brain Injury 4%
• Drug Therapy 4%
• Brain Injury 4%
• Botulinum Toxin 4%
• Muscle Tone 4%
• Peroneus Nerve Paralysis 4%